Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121315703 | 12131570 | 3 | F | 200201 | 20160715 | 20160301 | 20160721 | EXP | US-PFIZER INC-2016129640 | PFIZER | 54.00 | YR | F | Y | 0.00000 | 20160721 | LW | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121315703 | 12131570 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, 1X/DAY | U | 20702 | 80 | MG | FILM-COATED TABLET | QD | |||||
121315703 | 12131570 | 2 | C | ASPIRIN. | ASPIRIN | 1 | 81 (UNKNOWN UNITS), 2X/DAY | 0 | BID | ||||||||||
121315703 | 12131570 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121315703 | 12131570 | 1 | Blood cholesterol abnormal |
121315703 | 12131570 | 2 | Prophylaxis |
121315703 | 12131570 | 3 | Hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121315703 | 12131570 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121315703 | 12131570 | Emotional distress | |
121315703 | 12131570 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121315703 | 12131570 | 1 | 200001 | 200312 | 0 | |
121315703 | 12131570 | 2 | 1988 | 0 |